Disclosures Diabetes Care. 2015;38 (4):716-722. Summary By harnessing innovative technology, modern insulin pumps appear to provide clinically important and increasing benefits for people with ...

The t:slim X2 insulin pump is powered by Control-IQ+ technology, the latest generation of Tandem's advanced hybrid closed-loop algorithm, which adjusts insulin every 5 minutes based on predicted ...

SAN DIEGO, June 20, 2025--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control-IQ+ ...

Both companies will offer their engineering and development know-how to bring this patch pump to the market. PharmaSens CEO Marcel Both said: “This partnership marks a significant milestone toward ...

SAN DIEGO-- (BUSINESS WIRE)--Jun 20, 2025--The t:slim X2 insulin pump is powered by Control-IQ+ technology, the latest generation of Tandem's advanced hybrid closed-loop algorithm, which adjusts ...

OR access without expansion: MultiCare's 16% utilization gain and 1,600-case increase Recommended Live Webinar on Jul 31, 2025 1:00 PM - 2:00 PM CDT ...

In the first-of-its-kind analysis, the team of researchers looked at different study findings to discover what is needed in each training session to ensure muscle growth and strength gains.

BIEL/BIENNE, Switzerland, June 19, 2025 /PRNewswire/ -- PharmaSens AG, a Swiss developer of next-generation insulin patch pump systems, announced a strategic partnership with SiBionics, a leading ...

The Niia Essential insulin patch pump. [Image from PharmaSens on LinkedIn] PharmaSens today announced a strategic partnership with SiBionics to jointly develop an all-in-one insulin patch pump.

Key takeaways: Diabetes technologies have been evolving rapidly in recent years and now serve a wide range of patients. Usage is up for technologies such as automated insulin delivery and ...

Key Takeaways Pump.fun simplifies Solana meme coin creation, democratizing token launches for users without coding skills. It achieved explosive growth, generating over $700 million despite ...

[Image from Ypsomed] Ypsomed and CamDiab announced that they continued the launch of the iOS version of their automated insulin delivery app in Europe. The two companies in March began the launch of ...